Table 21.
Cardiovascular agents by type
| N (%) | |
|---|---|
| Alpha-2 agonist | 219 (31.6) |
| Clonidine | 163 (23.5) |
| Guanfacine | 54 (7.8) |
| Miscellaneousa | 2 (0.3) |
| Beta blockers | 154 (22.2) |
| Propranolol | 60 (8.7) |
| Metoprolol | 52 (7.5) |
| Carvedilol | 22 (3.2) |
| Atenolol | 6 (0.9) |
| Miscellaneousb | 14 (2.0) |
| Calcium channel blocker | 104 (15.0) |
| Amlodipine | 72 (10.4) |
| Diltiazem | 12 (1.7) |
| Verapamil | 11 (1.6) |
| Nifedipine | 9 (1.3) |
| Other antihypertensives and vasodilators | 61 (8.8) |
| Prazosin | 43 (6.2) |
| Hydralazine | 8 (1.2) |
| Miscellaneousc | 10 (1.4) |
| ACEI/ARB | 55 (7.9) |
| Lisinopril | 31 (4.5) |
| Losartan | 15 (2.2) |
| Miscellaneousd | 9 (1.3) |
| Diuretics | 36 (5.2) |
| Hydrochlorothiazide | 19 (2.7) |
| Spironolactone | 7 (1.0) |
| Furosemide | 5 (0.7) |
| Miscellaneouse | 5 (0.7) |
| Cardiac glycosides | 27 (3.9) |
| Digoxin | 26 (3.8) |
| Digitoxin | 1 (0.1) |
| Antidysrhythmics and other CV agents | 19 (2.7) |
| Flecainide | 7 (1.0) |
| Miscellaneousf | 12 (1.7) |
| Antihyperlipidemic | 18 (2.6) |
| Atorvastatin | 10 (1.4) |
| Miscellaneousg | 8 (1.2) |
| Class total | 693 (100) |
aIncludes xylazine and dexmedetomidine
bIncludes nebivolol, nadolol, labetalol, bisoprolol, and acebutolol
cIncludes tamsulosin, isosorbide, terazosin, nitroprusside, isobutyl nitrite, doxazosin, and antihypertensive unspecified
dIncludes valsartan, enalapril, perindopril, fosinopril, sacubitril and candesartan
eIncludes chlorthalidone, bumetanide, and acetazolamide
fIncludes sotalol, quinidine, propafenone, cardiovascular agent unspecified, amiodarone, and midodrine
gIncludes simvastatin, pravastatin, fenofibrate, and ezetimibe